Irlanda - anglès - HPRA (Health Products Regulatory Authority)

abbott laboratories ireland ltd - clarithromycin - film coated tablet - 500 milligram

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

g & a licensing limited - clarithromycin - film coated tablet - 500 milligram

Egipte - anglès - EDA (Egyptian Drug Authority)

abbott laboratories uk - sustained release tablets - 500 mg

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

abbott laboratories ireland ltd - clarithromycin - film coated tablet - 250 milligram

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

imbat limited - clarithromycin - film coated tablet - 250 milligram - macrolides

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

abbott laboratories ireland ltd - clarithromycin - film coated tablet - 500 milligram

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

g & a licensing limited - clarithromycin - film coated tablet - 500 milligram

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

imbat limited - clarithromycin - film coated tablet - 500 milligram - macrolides

Singapur - anglès - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - clarithromycin - injection, powder, for solution - 500 mg/vial - clarithromycin 500 mg/vial

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - clarithromycin - powder for concentrate for solution for infusion - 500 milligram(s) - macrolides; clarithromycin - antibacterial for systemic use, macrolide - it is indicated for treatment of infections caused by susceptible organisms in the following conditions: lower respiratory tract infections for example, acute and chronic bronchitis, and pneumonia. upper respiratory tract infections for example, sinusitis and pharyngitis. skin and soft tissue infections.